Cidara Therapeutics is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.
Cidara Therapeutics is a publicly traded company on NGM using the ticker symbol CDTX.
Detailed information on company financials and operating reports can be found here:
NGM: CDTX
Cidara Therapeutics Annual Revenue and Growth Rate
Note: Cidara Therapeutics's revenues are gauged from an analysis of company filings.
Investor Activity
Cidara Therapeutics has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.
Date
Investors
Percent Raised
Target Size
May 6, 2024
7
100%
$240 MM
Complete list of funding rounds and total amounts in the Company Report
Trademark Applications
Trademark applications show the products and services that Cidara Therapeutics is developing and marketing.
Cidara Therapeutics doesn't have any recent trademark applications, indicating Cidara Therapeutics is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
REZFORZIN Pharmaceutical and biological preparations to prevent and treat fungal infections and diseases
11/09/2020
XREZZO pharmaceutical and biological preparations for human use; pharmaceutical and biological preparations to prevent and treat fungal infections and diseases
11/09/2020
ZREZZO pharmaceutical and biological preparations for human use; pharmaceutical and biological preparations to prevent and treat fungal infections and diseases
11/09/2020
See all trademarks and details in the Full Report.
Market Share of Cidara Therapeutics's Largest Competitors
A competitive analysis shows these companies are in the same general field as Cidara Therapeutics, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Cidara Therapeutics.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Cidara Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.